Polpharma European CDMO Partner & API Manufacturer since 1951 Polpharma European CDMO Partner & API Manufacturer since 1951

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Find the latest Drugs in Development and Pipeline Prospector News of Merdury Pharmaceutical.

    Client Virtual Booth

    MERDURY PHARMACEUTICAL

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Send me more info on How To Grow My Bussiness Digitally?
    Merdury Pharmaceutical
    Taiwan Flag
    Country
    Country
    Taiwan
    Address
    Address
    15th Floor, No. 653, Bannan Road, Zhonghe District, New Taipei City
    Telephone
    Telephone
    886-2-8221-2020
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.en.merdury.com/
    Linkedin
    Linkedin
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Full View ScreenFull Screen View
    • Deals
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE

    ABVC BioPharma Announces Collaboration With MerDury BioPharma for New Product Development and Commercialization

    Details:

    The collaboration aims to develop new drug products by leveraging MerDury’s StackDose platform which has the technology to generate new products with unique fast-release properties when it is administered orally.


    Lead Product(s): Undislcosed

    Therapeutic Area: Technology Product Name: Undislcosed

    Highest Development Status: Discovery PlatformProduct Type: Undisclosed

    Partner/Sponsor/Collaborator: BIOKEY

    Deal Size: Undisclosed Upfront Cash: Undisclosed

    Deal Type: Collaboration June 06, 2023

    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content
    • Deals
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE

    Ainos and Merdury Sign MoU to Explore Phase 3 Study of VELDONA Drug Candidate for Treatment of Oral Warts in HIV-Seropositive Patients

    Details:

    Under the agreement, Ainos and Merdury will evaluate the feasibility of Merdury's potential investment and participation in the completion of a Phase 3 clinical trial of the Company's Veldona (interferon alfa) drug candidate for treatment of oral warts in HIV-seropositive patients.


    Lead Product(s): Interferon Alfa

    Therapeutic Area: Oncology Product Name: Veldona

    Highest Development Status: Phase IIProduct Type: Large molecule

    Partner/Sponsor/Collaborator: Ainos

    Deal Size: Undisclosed Upfront Cash: Undisclosed

    Deal Type: Agreement March 14, 2023

    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    minakem-m-2024-05-27

    Access Virtual Booth

    Contact Supplier

    Send me more info on How To Grow My Business Digitally?
    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search